Ignite Creation Date:
2025-12-24 @ 12:23 PM
Ignite Modification Date:
2026-02-02 @ 8:42 AM
Study NCT ID:
NCT02215161
Status:
TERMINATED
Last Update Posted:
2018-06-26
First Post:
2014-07-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer
Sponsor:
University of California, San Francisco
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Castration Levels of Testosterone | View |
| None | Hormone-Resistant Prostate Cancer | View |
| None | Metastatic Prostate Carcinoma in the Soft Tissue | View |
| None | Prostate Carcinoma Metastatic in the Bone | View |
| None | PSA Progression | View |
| None | Stage IV Prostate Adenocarcinoma AJCC v7 | View |
Keywords: